After Wall Street balked at Tesla‘s highly-anticipated robotaxi unveiling, CNBC’s Jim Cramer told investors not to make any moves on the stock. While he said he wouldn’t recommend buying Tesla after Thursday night’s event flopped, Cramer discouraged shorting the stock, saying it’s “dangerous to bet against” CEO Elon Musk.
“Even though Tesla’s robotaxi event was gorgeous, we didn’t get enough detail to justify treating this company like an autonomous driving business rather than an electric vehicle maker,” he said. “So, for now, I recommend taking a page from Switzerland and staying on the sidelines with this one.”
Tesla needed a win on Thursday, Cramer said. The stock was hammered earlier this year as the company posted a series of weak quarters. But shares gained traction in the spring as Musk teased self-driving cars, something that could differentiate Tesla from other electric vehicle makers — all of whom potentially face steep competition from Chinese companies.
While impressed by the look and concept of the robotaxi, Cramer said the event’s demonstration lacked substance and failed to prove its technological prowess. Musk provided few details about the actual costs of the vehicle, he added, and gave an “underwhelming” answer when asked about timing of the rollout.
By Friday’s close, Tesla stock was down 8.78%, and Cramer said the market’s reaction speaks for itself. While Tesla plunged, shares of Lyft and Uber rallied, with the latter hitting a new all-time high. The “existential threat” of robotaxis had weighed on the rideshare companies, but Wall Street doesn’t seem to be confident that Tesla’s Cybercab will be usable any time soon, he added.
“Look, Tesla has a big problem: the electric vehicle market turned out to be substantially smaller than was thought,” Cramer said. “If they want to pivot to self-driving cars, they need to really flesh that out, and last night we just didn’t get much in the way of specific details.”
Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram
Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com
ivermectin 6 mg for people – buy atacand tegretol 400mg ca
accutane buy online – buy generic decadron online buy linezolid without a prescription
order amoxicillin sale – valsartan 160mg pill buy ipratropium 100 mcg sale
azithromycin 250mg pill – tindamax 500mg pills bystolic 5mg us
order omnacortil 5mg online – buy prometrium cheap how to buy progesterone
purchase lasix online cheap – order piracetam 800 mg cheap betnovate
augmentin order online – buy generic augmentin 375mg buy generic duloxetine 20mg
purchase vibra-tabs generic – order glucotrol 5mg without prescription order glipizide 5mg generic
augmentin sale – ketoconazole 200mg for sale cymbalta 20mg ca
semaglutide 14 mg canada – buy vardenafil without a prescription purchase periactin for sale
buy zanaflex pills – purchase hydroxychloroquine online cheap hydrochlorothiazide order online
order cialis – cost cialis 5mg cost viagra 100mg
sildenafil 100mg pill – oral cialis 20mg cialis cost
lipitor 80mg brand – order atorvastatin 10mg zestril pills
purchase cenforce without prescription – aralen for sale glucophage 1000mg drug
buy lipitor 80mg sale – buy lisinopril 10mg pill prinivil online
buy prilosec generic – atenolol 50mg generic atenolol 100mg generic
clarinex 5mg usa – claritin 10mg brand dapoxetine 60mg without prescription
purchase cytotec sale – buy orlistat tablets diltiazem where to buy
domperidone uk – sumycin 250mg over the counter order generic cyclobenzaprine 15mg